Influence of losartan on the concentrations of bone morphogenetic protein 7 in patients with diabetic nephropathy

Chen Liqun,Yu Sujun,Gan Hua
DOI: https://doi.org/10.3969/j.issn.1671-8348.2011.23.012
2011-01-01
Abstract:Objective To investigate the influence of losartan on the concentration of bone morphogenetic protein 7(BMP-7) in patients with type 2 diabetic nephropathy.Methods 76 cases with DN were randomly divided into group A(losartan 50 mg /d,n=40) and group B(losartan 100 mg /d,n=36).Their 24 h urinary protein,serum creatinine,blood urea nitrogen,serum lipids,serum potassium,TGF-β1 and BMP-7 in serum and urine were measured respectively before and after therapy.Results Compared with pre-therapy,24 h urinary protein,serum creatinine and blood urea nitrogen decreased significantly in two groups after therapy(P<0.05),24 h urinary protein was much lower in group B than group A(P<0.05);the serum lipids and serum potassium were changed slightly in two groups,and there was no statistical difference(P>0.05).The concentrations of TGF-β1 in serum and urine were decreased significantly in two groups after therapy(P<0.05);but the concentrations of BMP-7 in serum and urine were increased significantly in two groups after therapy(P<0.05).The correlation analysis were manifested:in two groups,there was a positive correlation between 24 h urinary protein and concentrations of TGF-β1 in urine(r=0.852,P<0.01),there was a negative correlation between 24 h urinary protein and concentrations of BMP-7 in urine(r=-0.744,P<0.05);and there was a negative correlation between concentrations of TGF-β1 and BMP-7 in urine(r=-0.690,P<0.05).Conclusion Losartan up-regulates the concentrations of BMP-7 in serum and urine and decreases the concentrations of TGF-β1 in serum and urine in patients with type 2 diabetic nephropathy,meanwhile it helps to reduce the proteinuria and improve renal function.
What problem does this paper attempt to address?